Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Chronic Pelvic Pain in Women
NCT02918760Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin in chronic pelvic pain (CPP), sponsored by Ain Shams University. Primary endpoint: Visual Analogue Scale at 6 months. Status: unknown.
02
Drugs
gabapentin
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT02918760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918760.